Viewing Study NCT00258258


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-29 @ 1:42 PM
Study NCT ID: NCT00258258
Status: TERMINATED
Last Update Posted: 2013-02-01
First Post: 2005-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma and Plasma Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory multiple myeloma View